18F-FDG-PET/CT can be used to predict distant metastasis in hypopharyngeal squamous cell carcinoma

被引:2
|
作者
Suzuki, Shinsuke [1 ]
Toyoma, Satoshi [1 ]
Abe, Tomoe [1 ]
Endo, Tentaro [1 ]
Kouga, Teppei [1 ]
Kaswasaki, Yohei [1 ]
Yamada, Takechiyo [1 ]
机构
[1] Akita Univ, Dept Otorhinolaryngol & Head & Neck Surg, Grad Sch Med, Akita 0108543, Japan
关键词
Hypopharyngeal squamous cell carcinoma; Distant metastasis; 18F-FDG-PET/CT; Maximum standardized uptake value; Survival; METABOLIC TUMOR VOLUME; PROGNOSTIC VALUE; NECK-CANCER; FDG-PET; HEAD; SURVIVAL; CHEMORADIOTHERAPY; CHEMOTHERAPY; CETUXIMAB; RECURRENT;
D O I
10.1186/s40463-022-00568-8
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background: Hypopharyngeal squamous cell carcinoma (HPSCC) has a high rate of distant metastasis, resulting in poor prognosis. The role of the maximum standardized uptake value (SUVmax), which was assessed via pretreatment 18-fluorodeoxyglucose positron emission tomography (FDG-PET), and computed tomography (CT) was examined, for predicting distant metastasis and survival. Methods: This study included 121 patients who underwent pretreatment FDG-PET/CT scanning and subsequent treatment for HPSCC. The SUVmax was measured via FDG-PET/CT. A receiver operating characteristic (ROC) curve analysis was used to determine whether the SUVmax was a predictor of distant metastasis and to select the best cutoff value. Univariate and multivariate Cox hazard regression analyses were used in identifying associations between the SUVmax and other clinicopathological factors with distant metastasis-free survival. Results: Distant metastases were identified in 33 patients during the median follow-up of 24 months after treatment. The ROC curve analysis determined that SUVmax was predictive of distant metastasis and identified a SUVmax of 13.9 as the best potential cutoff value. The univariate analysis showed that T and N classification, clinical stage, and SUVmax were significantly related to distant metastasis. However, in multivariate analysis, an SUVmax >= 13.9 was the only independent predictor of distant metastasis. Patients with high SUVmax values displayed significantly shorter distant metastasis-free survival and overall survival. Conclusions: SUVmax determined via pretreatment FDG-PET/CT is useful for predicting distant metastasis, distant metastasis-free survival, and overall survival in patients with HPSCC.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Head and neck squamous cell carcinoma (HNSCC) – detection of synchronous primaries with 18F-FDG-PET/CT
    Klaus Strobel
    Stephan K. Haerle
    Sandro J. Stoeckli
    Madeleine Schrank
    Jan D. Soyka
    Patrick Veit-Haibach
    Thomas F. Hany
    European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36 : 919 - 927
  • [22] Head and neck squamous cell carcinoma (HNSCC) - detection of synchronous primaries with 18F-FDG-PET/CT
    Strobel, Klaus
    Haerle, Stephan K.
    Stoeckli, Sandro J.
    Schrank, Madeleine
    Soyka, Jan D.
    Veit-Haibach, Patrick
    Hany, Thomas F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 (06) : 919 - 927
  • [23] 18F-FDG-PET/CT for the Assessment of the Contralateral Neck in Patients with Head and Neck Squamous Cell Carcinoma
    Kastrinidis, Nikos
    Kuhn, Felix P.
    Hany, Thomas F.
    Ahmad, Nader
    Huber, Gerhard F.
    Haerle, Stephan K.
    LARYNGOSCOPE, 2013, 123 (05): : 1210 - 1215
  • [24] Adhesive Capsulitis Mimicking Metastasis on 18F-FDG-PET/CT
    Salem, Usama
    Zhang, Liping
    Jorgensen, Jeffrey L.
    Kumar, Rajendra
    Amini, Behrang
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (02) : E145 - E147
  • [25] 18F-FDG PET/CT in evaluation of squamous cell carcinoma
    Milojevic, Isidora Grozdic
    Milojevic, Bogomir
    Sobic-Saranovic, Dragana
    Pantic, Nikola
    Zivanovic, Jovana
    Artiko, Vera M.
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2023, 26 (02) : 99 - 107
  • [26] Pancreatic small cell carcinoma incidentally detected by 18F-FDG-PET/CT
    Treglia, Giorgio
    Bongiovanni, Massimo
    Giovanella, Luca
    PANCREATOLOGY, 2014, 14 (01) : 81 - 82
  • [27] 18F-FDG-PET/CT in myelofibrosis
    Behrendt, F. F.
    Krohn, T.
    Palmowski, M.
    Mottaghy, F. M.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2011, 50 (06): : N66 - N67
  • [28] 18F-FDG-PET/CT and FUO
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (02) : 19N - 19N
  • [29] 18F-FDG-PET/CT in assessment of post radiation changes in patients with head and neck squamous cell carcinoma
    Daugherty, Emily
    Raslan, Osama
    Bicklein, S.
    Kienstra, K.
    Hewing, Debra
    Osman, Medhat
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [30] 18F-FDG-PET/CT in assessment of post radiation changes in patients with head and neck squamous cell carcinoma
    Daugherty, Emily
    Raslan, Osama
    Bicklein, S.
    Kienstra, K.
    Hewing, Debra
    Osman, Medhat
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55